Prelude Capital Management’s Abiomed Inc ABMD Stock Holding History

Prelude Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-100	Closed	-$17K	–	1819
2017 Q3	$17K	Buy	+100	New	+$15.1K	﹤0.01%	1353

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Prelude Capital Management's ABMD Position: Q4 2022 in Review

Prelude Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,013 shares — an estimated $249K sold.

Prelude Capital Management first reported a position in ABMD in Q4 2013 and held it in 19 quarters. The position peaked at $704K in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Prelude Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Prelude Capital Management sold 1,013 Abiomed Inc shares in Q4 2022, an estimated $249K.
Prelude Capital Management first reported a position in Abiomed Inc in Q4 2013 and held it in 19 quarters.
Prelude Capital Management's Abiomed Inc position peaked at $704K in Q2 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.